A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

July 31, 2004

Study Completion Date

September 30, 2005

Conditions
SupportiveIll-defined Sites
Interventions
DRUG

paclitaxel, docetaxel, taxane

1 mg paclitaxel or docetaxel test dose is prepared in 3 ml of normal saline and administered over two to five minutes IV push at least 30 minutes after prescribed IV and PO pre-medications. If no discernable adverse reaction ensues, the balance of the taxane dose is prepared and administered as per standard or specific chemotherapy protocol.

DRUG

taxane

The full taxane dose is prepared and administered as per standard or specific chemotherapy protocol, at least 30 minutes after prescribed IV and PO pre-medications.

Trial Locations (1)

87131

University of New Mexico, Albuquerque

All Listed Sponsors
lead

New Mexico Cancer Research Alliance

OTHER

NCT00277043 - A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes | Biotech Hunter | Biotech Hunter